| Product Code: ETC6575739 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Burkina Faso`s non-steroidal anti-inflammatory drugs import market in 2024 saw consistent high concentration with top exporters being India, France, Ghana, Morocco, and China. Despite a slight decline in the compound annual growth rate from 2020 to 2024 at -0.46%, there was a notable growth spurt of 10.24% from 2023 to 2024. This indicates a fluctuating market with potential for further expansion and diversification. The competitive landscape remains robust, offering opportunities for stakeholders to capitalize on the growing demand for these pharmaceutical products in Burkina Faso.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2022 & 2032F |
3.3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle |
3.4 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces |
3.5 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
3.7 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as arthritis and musculoskeletal disorders |
4.2.2 Rising geriatric population in Burkina Faso |
4.2.3 Growing awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and access to quality healthcare services in remote areas |
4.3.2 Regulatory challenges and stringent approval processes for pharmaceutical products in Burkina Faso |
5 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Trends |
6 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market, By Types |
6.1 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2022 - 2032F |
6.1.3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2022 - 2032F |
6.1.4 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2022 - 2032F |
6.1.5 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2022 - 2032F |
6.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2022 - 2032F |
6.2.3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2022 - 2032F |
6.2.4 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2022 - 2032F |
6.2.5 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.3.3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.3.4 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
7 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics |
7.1 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries |
7.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries |
8 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators |
8.1 Number of new product launches in the NSAIDs market |
8.2 Percentage of healthcare professionals recommending NSAIDs |
8.3 Patient adherence rate to NSAIDs treatment |
8.4 Level of government initiatives to improve healthcare infrastructure |
8.5 Number of clinical trials conducted for NSAIDs in Burkina Faso |
9 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment |
9.1 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
9.3 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape |
10.1 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2025 |
10.2 Burkina Faso Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here